Evidence map›Paper›PMID 39294189›Full record

ArticleScientific reports2024

The comparison of pathogenicity among SARS-CoV-2 variants in domestic cats.

Eun-Sil Park, Yudai Kuroda, Akihiko Uda, Yoshihiro Kaku, Akiko Okutani, Akitoyo Hotta, Kango Tatemoto, Keita Ishijima, Yusuke Inoue, Michiko Harada and 13 more

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Eun-Sil Park *Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Yudai Kuroda *Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Akihiko UdaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Yoshihiro KakuDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Akiko OkutaniDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Akitoyo HottaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Kango TatemotoDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Keita IshijimaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Yusuke InoueDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Michiko HaradaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Yasushi AmiResearch Center for Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Masayuki ShirakuraResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Musashimurayama, 208-0011, Japan.
Shinji WatanabeResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Musashimurayama, 208-0011, Japan.
Yasushi SuzukiResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Musashimurayama, 208-0011, Japan.
Toshihiko HaradaResearch Center for Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Akira AinaiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Nozomi ShiwaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Yusuke SakaiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Naoko Iwata-YoshikawaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Noriyo NagataDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Hideki HasegawaResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Musashimurayama, 208-0011, Japan.
Ken MaedaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan. kmaeda@niid.go.jp.

Funding

Environment Research and Technology Development Fund 4-2005Health and Labour Sciences Research Grants 23HA2010Japan Agency for Medical Research and Development JP19fk0108112Japan Agency for Medical Research and Development JP21fk0108615Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response 223fa727002
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been detected or isolated from domestic cats. It is unclear whether cats play an important role in the SARS-CoV-2 transmission cycle. In this study, we examined the susceptibility of cats to SARS-CoV-2, including wild type and variants, by animal experiments. Cats inoculated with wild type, gamma, and delta variants secreted a large amount of SARS-CoV-2 for 1 week after the inoculation from nasal, oropharyngeal, and rectal routes. Only 100 TCID

Indexed as

Antibodies, NeutralizingAntibodies, ViralCOVID-19SARS-CoV-2AnimalsCat DiseasesCatsFecesFemaleAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID39294189
PMCPMC11410826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.